As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Medicilon is delighted to announce that Dr. Xiaodong (Mark) Zhang has joined us to further develop the growing Preclinical Research accounts. Dr. Zhang comes with a wealth of experience within this field.
Picture of Dr.zhang
Dr. Zhang was the VP of Preclinical Research, Deputy Director of Department of Health Toxicology, SMMU; Deputy Director of Center for Evaluation of Drug Safety, SMMU; Drug Reviewer of Center for Drug Evaluation , CFDA and expert for Drug Consulting, Center for Drug Evaluation , CFDA.
Just as Dr. Chunlin Chen, CEO of Medicilon, said, “I’m confident that Mark will play a key role in providing and implementing high quality solutions for our clients.”